Brief: Ekso Bionics Says Q2 Revenue Rose 57% To $3.5 Million
28/07/2022 22:55
July 28 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS SECOND QUARTER 2022 RESULTS
* Q2 REVENUE ROSE 57 PERCENT TO $3.5 MILLION
* Q2 LOSS PER SHARE $0.23
Source text for Eikon: ID:nGNX3B7GrP
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale